Virtual Exhibition Hall

At Olympus we aim to deliver total medical solution with complete customer satisfaction. Our medical products cover gastrointestinal endoscopes, endotherapy devices, endoscopic ultrasound systems, surgical endoscopes and instruments and integrated operating theatre. As a leading endoscope company, Olympus is promoting the advancement of minimally invasive diagnosis and treatment as well as product development to offer our customers improved safety, security, quality and productivity. 

Applied Medical designs, develops and manufactures innovative products that enable advanced surgical procedures and optimise patient outcomes. We fuel the continuous development of new technologies to advance healthcare by maintaining a high commitment to R&D. Each year Applied Medical dedicates, on average, 20% of our revenue to product development, as well as to projects that increase the efficiency of our manufacturing operations. As a result of our dedication to R&D and improving patient outcomes, we are a leading provider of breakthrough technologies for minimally invasive and general surgery, as well as urologic, colorectal, bariatric, obstetric and gynaecologic specialties. 

Baxter touches the lives of millions of people around the world every day. Our products and therapies can be found throughout hospitals and clinics – from the ER to the OR, from the pharmacy to the ICU – as well as advancing patients’ care in their homes.
For more than 85-years, we have been at the critical intersection of saving and sustaining lives. And now, we are determined and uniquely positioned to realize our greatest opportunity to transform global healthcare for years to come. 

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.

B. Braun is one of the world’s leading providers and manufacturers of healthcare solution today. For more than 180 years, we develop innovative and effective solutions to protect and improve the health of people around the world.

The Hospital Care Division of B. Braun offers a complete product portfolio in Total Parenteral Nutrition, Plasma Volume Replacement, Central Venous Catheters as well as a selected range of Added Value Generics, mainly IV Anesthetics & convenience Antibiotics. Our products have long been used in well-established markets.

The Aesculap division has been synonymous with competence in the operating room for over 150 years. The division is a partner for surgical and interventional treatment concepts in inpatient and outpatient care. Aesculap focuses on the following therapeutic areas: abdominal surgery, cardiothoracic surgery, orthopedic surgery, spine surgery, neurosurgery, interventional vascular therapy and sterile goods management.​​​​​​​​​​​​​​

Cornerstone Robotics (CSR) is an innovative surgical robotics unicorn driven by the vision of leading medical innovations for a healthier world. We advance surgical care with cutting-edge robotic systems to make high-quality healthcare more accessible and efficient globally. With three global R&D hubs and six business centers worldwide, we have established a 30,000-square-meter manufacturing facility in the Greater Bay Area. Developed entirely in-house, the Sentire® Endoscopic Surgical System has successfully completed multicenter clinical trials in Hong Kong, China and the United Kingdom and has received regulatory approvals in China, the European Union, Singapore and Indonesia. Indicated for key specialties including general surgery, gynecology, thoracic and urology, the Sentire® System provides advanced minimally invasive surgical solutions to healthcare professionals worldwide, helping expand access to high-quality surgical care and improve patient outcomes globally. 

Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. In the field of biosimilar, we focus on autoimmune disease and oncolgoy. In 2019, The first biosimliar product by Fresenius kabi was launched. Within transfusion medicine and ceth therapies, Fresenius kabi offers products for collection of blood components and extracorporeal therapies.

Johnson & Johnson MedTech is an American multinational medical technology company at the forefront of innovation in surgical care worldwide. Renowned as a leading global healthcare innovator, J&J MedTech is committed to innovation, clinical excellence, and a patient-centric approach. Specifically, J&J Surgery under J&J Med Tech is dedicated to advancing minimally invasive and precision surgical techniques by offering a comprehensive portfolio of cutting-edge solutions, including wound closure, biosurgery, energy devices, surgical stapling systems and robotics.

Guided by the principles of the J&J Credo, the company places the needs and well-being of the people it serves first. J&J prioritizes the health and safety of patients and healthcare professionals, ensuring that quality, safety, and efficacy are paramount. The company also emphasizes its responsibility to shareholders by maintaining ethical business practices and promoting sustainable growth. J&J Surgery aims to improve surgical outcomes, reduce patient recovery times, and enhance overall healthcare delivery. As a trusted leader in the field, J&J Surgery continues to push the boundaries of medical science, supporting surgeons in Hong Kong and around the world. J&J remains dedicated to advancing surgical care and improving lives globally and committed to reimagining how we heal.

Since its beginnings in 1945, the KARL STORZ family company has grown into a global manufacturer and distributor of endoscopes, medical instruments, and devices. We are no giant on an international scale but a leader in the things that matter: creativity, flexibility, and expertise.

Our range of endoscopic instruments for human medicine, veterinary medicine, and industrial endoscopy now includes more than 15,000 products. The most recent KARL STORZ developments are in digital documentation systems and comprehensive operating room concepts. As a system supplier, the company combines its expertise in endoscopy with software solutions to achieve integration in the operating room and to support clinical process and resource management.

Merck KGaA, Darmstadt, Germany, is a leading science and technology company with businesses spanning Healthcare, Life Science and Electronics. Founded in 1668, the company has a long-standing heritage of scientific exploration, innovation and responsible entrepreneurship. For more than 350 years, Merck has applied its scientific expertise to develop solutions that support human health, advance research and enable technological progress.
Today, approximately 63,000 employees worldwide work to develop products, services and technologies for patients, healthcare professionals, researchers and industries. Within Healthcare, Merck focuses on selected therapeutic areas, including cardiometabolic, endocrinology, oncology, neurology. Through these areas, the company seeks to address important medical needs and contribute to the continued advancement of patient care.

Merck has a long history in thyroid disease management and markets Euthyrox® (levothyroxine sodium), a branded thyroid hormone replacement medicine indicated for the management of hypothyroidism with precision, in accordance with locally approved prescribing information. By providing an established treatment option, Euthyrox supports the long-term management of patients whose thyroid hormone levels require replacement.

Merck remains committed to scientific excellence and to working with healthcare professionals and the scientific community to advance understanding of disease and treatment. 

MicroPort Scientific (00853.HK), founded in 1998 and listed in Hong Kong in 2010, develops high-end devices to extend and reshape lives at accessible cost. Products serve over 20,000 hospitals in cardiovascular, orthopedic, rhythm, vascular, neuro, structural heart and intelligent surgery. It has sites in China, the US and Europe, and over 12,000 patents.
MicroPort MedBot (02252.HK), incubated in 2014 and listed in 2021, offers commercial robots in five tracks: multi- and single-port laparoscopy, orthopedics, endovascular, percutaneous, and bronchoscopic or natural-orifice systems, targeting a full intelligent-surgery ecosystem.
Flagship Toumai has 300-plus commercial orders and over 200 installations, plus more than 200 new orders from October 2025 to July 2026. Over 25,000 clinical cases and 1,200 remote procedures have been completed, including 5G, dedicated-line and Starlink links and a China-to-Brazil remote case. A Gemelli study in Cancers found robot-assisted prostatectomy early outcomes non-inferior and cost-effective.
The console has five groups and ten-direction adjustment, eight fluorescence modes, instruments reusable 20 times, and built-in simulation. Support includes 14 training centres, 32 spare-parts hubs, 24/7 factory service and a Southeast Asia team. Systems are installed across ASEAN, India, Bangladesh, Sri Lanka and elsewhere. 

Nanjing Jiadel Medical Co., Ltd. is a specialized company dedicated to providing medical institutions with medical devices and consumables. One of our core businesses is introducing advanced medical devices and consumables from overseas markets into China.The company’s core management team has more than 20 years of experience working for multinational corporations, giving them an in-depth understanding of the current landscape and future development trends of medical devices and consumables in international markets. Nanjing Jiadel maintains close partnerships with internationally renowned companies specializing in the R&D and manufacturing of medical devices and consumables, while also having well-established sales and distribution channels in China. All these strengths enable Nanjing Jiadel to serve as an effective bridge for international medical device and consumable companies seeking to enter the Chinese market. Nanjing Jiadel is the exclusive distributor of Cranial Loop and Cranial Cover in Mainland China, Hong Kong, Macau.

Founded in 1921, the Otsuka Pharmaceutical Factory Inc. began producing intravenous solutions in 1946 and then Otsuka Pharmaceutical Co., Ltd. (Otsuka Pharmaceutical) was established in 1964. Through its nutritional therapies provided in clinical care, it has secured a leadership position in this field. In 1971, Otsuka Pharmaceutical also began developing various pharmaceutical products. In addition, leveraging the expertise and experience gained from the pharmaceutical manufacturing process, Otsuka Pharmaceutical applied this knowledge to the development of nutraceutical products. Today, Otsuka Pharmaceutical's global leadership in pharmaceuticals, nutrition, and health care is widely recognized.

In 1997, Otsuka Pharmaceutical (Hong Kong) Limited (Otsuka Hong Kong) was officially established. As a subsidiary of Otsuka Pharmaceutical in Japan, Otsuka Hong Kong is primarily responsible for the marketing and sales of Otsuka Pharmaceutical Group products in Hong Kong and Macau.

With societal changes and economic development, the demand for healthcare products among Hong Kong residents is rapidly increasing. Several Otsuka Pharmaceutical products have successfully penetrated the health and pharmaceutical markets, making significant contributions to the health of the people in Hong Kong. Among these are some well-known products, such as Pocari Sweat, Oronine H Ointment, Aminoleban EN, Pletaal and Abilify.

Based in Hong Kong, Pacific Medical Systems Ltd is a leading provider of innovative and quality surgical products in Asia since 2004. Initially focusing in cardiovascular surgery with products such as Medistim ultrasonic guidance and graft assessment systems, lightweight Xenosys loupes, headlights and surgical video documenting systems, CoroNeo and Rultract specialty retractors, Lifotronic, warmer unit with disposable blanket, LSI Cor-Knot devices, Medela digital chest drainage system, Praesidia sternal closure systems,; and recently complementing with our GE cardiovascular and MSK ultrasound systems with the bespoke Episurf patient customized knee and talus device implants for the orthopedic segment.

Servier, founded in 1954, is the first French independent pharmaceutical group. We are present in over 150 countries with more than 21,000 employees worldwide.

Our special status as a laboratory governed by a foundation means each year, we can invest over 20% of our revenue from brand-name medicines in research and development, a strategy that helps us to discover new treatments more easily.

Day in, day out, we capitalize on the talent and engagement of the 21,400 people employed throughout our Group to make our brand-name and generic medicines available to patients in over 150 countries.

These medicines are the fruit of our knowledge and expertise in our therapeutic areas of oncology, neuroscience, immuno-inflammation, cardiovascular diseases, and metabolism.